The Burden of Human African Trypanosomiasis
Author Information
Author(s): Eric M. Fèvre, Beatrix v. Wissmann, Susan C. Welburn, Pascal Lutumba
Primary Institution: Centre for Infectious Diseases, University of Edinburgh
Hypothesis
What is the current burden of Human African Trypanosomiasis (HAT) in sub-Saharan Africa?
Conclusion
The study highlights significant gaps in data regarding the burden of HAT, emphasizing the need for improved data collection to better assess its impact.
Supporting Evidence
- Approximately 60 million people are at risk of HAT in sub-Saharan Africa.
- Two-thirds of reported T.b. gambiense cases occur in the Democratic Republic of Congo.
- Estimates suggest that up to 70,000 cases of HAT occur annually, including unreported cases.
Takeaway
Human African trypanosomiasis, or sleeping sickness, is a serious disease in Africa, but we don't know exactly how many people are affected because many cases go unreported.
Methodology
The review focuses on existing data sources and methodological issues related to the use of disability-adjusted life years (DALYs) for assessing disease burden.
Potential Biases
Potential biases in data collection methods and the reliance on reported cases may skew the understanding of the disease burden.
Limitations
The study notes significant under-reporting of cases and a lack of comprehensive data on the disease's impact.
Participant Demographics
The disease primarily affects populations in sub-Saharan Africa.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website